Inhibition of B cell receptor-mediated B cell activation by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

被引：0
|
作者：
Szymkowski, David E. [1 ]
Chu, Seung Y. [1 ]
Vostiar, Igor [1 ]
Horton, Holly M. [1 ]
Karki, Sher [1 ]
Moore, Gregory L. [1 ]
Lazar, Greg A. [1 ]
Pong, Erik [1 ]
Joyce, Patrick F. [1 ]
Desjarlais, John [1 ]
机构：
[1] Xencor Inc, Monrovia, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [31] SWITCHING OFF B CELLS BY FC-ENGINEERED ANTI-CD19 ANTIBODY (XmAb5871)
    Szili, Daniel
    Cserhalmi, Marcell
    Banko, Zsuzsanna
    Nagy, Gyorgy
    Szymkowski, David E.
    Sarmay, Gabriella
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A37 - A37
  • [32] An Fc-optimized CD19 antibody as treatment option for lymphoid B-cell malignancies
    Seidel, U. J.
    Grosse-Hovest, L.
    Schlegel, P.
    Hofmann, M.
    Vogt, F.
    Schuster, F. R.
    Meisel, R.
    Witte, K.
    Aulwurm, S.
    Pyz, E.
    Rammensee, H.
    Jung, G.
    Handgretinger, R.
    Lang, P.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E25 - E25
  • [33] B-CELL-STIMULATORY FACTOR-I REVERSES FC-RECEPTOR-MEDIATED INHIBITION OF LYMPHOCYTE-B ACTIVATION
    OGARRA, A
    RIGLEY, KP
    HOLMAN, M
    MCLAUGHLIN, JB
    KLAUS, GGB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6254 - 6258
  • [34] An Fc-Engineered CD19 Antibody Engages Macrophages and Is Effective in Xenograft Models of Pediatric Acute Lymphoblastic Leukemia
    Schewe, Denis M.
    Alsadeq, Ameera
    Cario, Gunnar
    Vieth, Simon
    Valerius, Thomas
    Schrappe, Martin
    Gramatzki, Martin
    Peipp, Matthias
    Kellner, Christian
    BLOOD, 2016, 128 (22)
  • [35] FC-DEPENDENT INHIBITION OF MOUSE B-CELL ACTIVATION
    PHILLIPS, NE
    PARKER, DC
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 690 - 690
  • [36] Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition
    Aminov, Sarah
    Giricz, Orsi
    Sica, R. Alejandro
    Polishchuk, Veronika
    Yates, Bonnie
    Wang, Hao-Wei
    Wang, Yanhua
    Sahu, Srabani
    Gordon, Shanisha
    Schinke, Carolina
    Pradhan, Kith
    Aluri, Srinivas
    Janakiram, Murali
    Barta, Stefan K.
    Agarwal, Beamon
    Goldfinger, Mendel
    Shastri, Aditi
    Matsui, William
    Steidl, Ulrich
    Brody, Joshua
    Shah, Nirali N.
    Parekh, Samir
    Verma, Amit
    BLOOD, 2022, 140 : 3480 - 3481
  • [37] FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells
    Jackson, Tanisha A.
    Haga, Christopher L.
    Ehrhardt, Goetz R. A.
    Davis, Randall S.
    Cooper, Max D.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (12): : 7405 - 7412
  • [38] B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fcγ receptors
    Tanguay, D
    Pavlovic, S
    Piatelli, MJ
    Bartek, J
    Chiles, TC
    JOURNAL OF IMMUNOLOGY, 1999, 163 (06): : 3160 - 3168
  • [39] Inhibition of B cell receptor-mediated apoptosis by IFN
    Su, L
    David, M
    JOURNAL OF IMMUNOLOGY, 1999, 162 (11): : 6317 - 6321
  • [40] FcγRIIB-mediated dissociation of BCR-CD19 microclusters and hyperreactivity of lupus B cells
    Liu, Wanli
    Xu, LiLing
    JOURNAL OF IMMUNOLOGY, 2014, 192
12345